Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | MGAM | O43451 | 1/20 | 0.43 |
| ▸ | SI | P14410 | 1/20 | 0.43 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.40 |
| ▸ | MMP8 | P22894 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.37 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1866533 | 1.00 | GAA (0.43) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL27696749 | 0.93 | MGAM (0.38) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL13050770 | 0.88 | MMP1 (0.31) | MMP8 | |
| SCHEMBL19742741 | 0.87 | MMP8 (0.36) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL19742725 | 0.86 | CYP19A1 (0.35) | GAAMGAMSIMGAM2MMP8 | |
| SCHEMBL8041406 | 0.85 | NAAA (0.33) | ALDH1A1 | |
| SCHEMBL5972479 | 0.83 | GAA (0.55) | GAAMGAMSIMGAM2ALDH1A1 | |
| SCHEMBL12987682 | 0.82 | — | — | |
| SCHEMBL4393275 | 0.82 | — | — | |
| SCHEMBL7228511 | 0.82 | SERPINE1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 163 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12398341-B2 | Apparatus and compositions for improving scent delivery | THE PROCTER & GAMBLE COMPANY (US) | 2025-08-26 | — | — | US | claimed |
| US-12247180-B2 | Apparatus and compositions for improving scent delivery | THE PROCTER & GAMBLE COMPANY (US) | 2025-03-11 | — | — | US | claimed |
| EP-4356894-A1 | SUSTAINABLE PRODUCT WITH MALODORS | Beiersdorf AG (DE) | 2024-04-24 | — | — | EP | claimed |
| EP-4175682-A1 | APPARATUS AND COMPOSITIONS FOR IMPROVING SCENT DELIVERY | The Procter & Gamble Company (US) | 2023-05-10 | — | — | EP | claimed |
| EP-4175680-A1 | APPARATUS AND COMPOSITIONS FOR IMPROVING SCENT DELIVERY | The Procter & Gamble Company (US) | 2023-05-10 | — | — | EP | claimed |
| WO-2022006197-A1 | APPARATUS AND COMPOSITIONS FOR IMPROVING SCENT DELIVERY | THE PROCTER & GAMBLE COMPANY (US) | 2022-01-06 | — | — | WO | claimed |
| WO-2022006198-A1 | APPARATUS AND COMPOSITIONS FOR IMPROVING SCENT DELIVERY | THE PROCTER & GAMBLE COMPANY (US) | 2022-01-06 | — | — | WO | claimed |
| US-20220002633-A1 | APPARATUS AND COMPOSITIONS FOR IMPROVING SCENT DELIVERY | THE PROCTER AND GAMBLE COMPANY | 2022-01-06 | — | — | US | claimed |
| US-20220002632-A1 | APPARATUS AND COMPOSITIONS FOR IMPROVING SCENT DELIVERY | THE PROCTER AND GAMBLE COMPANY | 2022-01-06 | — | — | US | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| EP-3309245-A1 | ENCAPSULATES | The Procter & Gamble Company (US) | 2018-04-18 | — | — | EP | claimed |
| EP-2512406-B1 | PERFUMES AND PERFUME ENCAPSULATES | PROCTER & GAMBLE (US) | 2018-01-24 | — | — | EP | claimed |
| EP-2512406-A1 | PERFUMES AND PERFUME ENCAPSULATES | The Procter & Gamble Company (US) | 2012-10-24 | — | — | EP | claimed |
| EP-2513280-A1 | COMPOSITION COMPRISING ENCAPSULATES, AND PROCESS FOR MAKING THEM | The Procter & Gamble Company (US) | 2012-10-24 | — | — | EP | claimed |
| CN-102695491-A | Perfumes and perfume encapsulates | PROCTER & GAMBLE | 2012-09-26 | — | — | CN | claimed |
| WO-2011075556-A1 | COMPOSITION COMPRISING ENCAPSULATES, AND PROCESS FOR MAKING THEM | THE PROCTER & GAMBLE COMPANY (US) | 2011-06-23 | — | — | WO | claimed |
| WO-2011075551-A1 | PERFUMES AND PERFUME ENCAPSULATES | THE PROCTER & GAMBLE COMPANY (US) | 2011-06-23 | — | — | WO | claimed |
| US-12577511-B2 | Agent containing emulsifier and microcapsules | HENKEL AG & CO. KGAA (DE) | 2026-03-17 | — | — | US | disclosed |
| US-20040254258-A1 | Polymerizable composition, optical material comprising the composition and method for producing the material | MITSUBISHI GAS CHEMICAL CO., LTD. (JP) | 2004-12-16 | — | — | US | disclosed |
| US-4267075-A | SAID ESTERS BEING ALKYL, ALKENYL, OR ALKYNYL ESTERS | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1981-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577511-B2 | Agent containing emulsifier and microcapsules | LIPA, CUTA, MGLL | GAA 1306/4885MGAM 551/4885SI 3158/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.